RAPT Therapeutics, Inc. (RAPT)

Mar 3, 2026 - RAPT was delisted (reason: acquired by GSK)

58.02

0.00 (0.00%)

Inactive · Last trade price on Mar 2, 2026

RAPT Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,794	213	855	672	1,085	485
Market Cap Growth	1042.12%	-75.05%	27.19%	-38.08%	123.77%	-19.54%
Enterprise Value	1,639	120	677	484	874	362
Last Close Price	58.02	12.64	198.80	158.40	293.84	158.00

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	-	-	-	440.09	284.61	96.19
PB Ratio	6.43	1.12	5.81	2.74	5.82	4.66
P/TBV Ratio	11.81	1.12	5.81	2.74	5.82	4.66

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
EV/Sales Ratio	-	-	-	317.25	229.33	71.83

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	0.02	0.02	0.05	0.04	-	-
Net Debt / Equity Ratio	-1.02	-1.19	-1.03	-0.98	-1.02	-1.07
Net Debt / EBITDA Ratio	1.39	1.68	1.21	2.83	2.78	2.14
Net Debt / FCF Ratio	1.79	2.72	1.55	3.35	3.07	2.73
Asset Turnover	-	-	-	0.01	0.02	0.05
Quick Ratio	11.76	4.78	7.28	17.51	19.77	9.50
Current Ratio	12.04	4.87	7.41	17.77	20.11	9.85
Return on Equity (ROE)	-85.37%	-77.09%	-59.56%	-38.86%	-47.63%	-59.66%
Return on Assets (ROA)	-51.35%	-41.13%	-36.13%	-23.07%	-27.24%	-32.67%
Return on Capital Employed (ROCE)	-73.90%	-70.90%	-83.90%	-34.00%	-36.60%	-49.60%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Earnings Yield	-5.89%	-60.90%	-13.66%	-12.48%	-6.38%	-10.91%
FCF Yield	-4.83%	-39.12%	-11.49%	-10.66%	-5.69%	-8.43%
Buyback Yield / Dilution	-347.95%	-6.32%	-17.82%	-18.80%	-13.49%	-455.27%

SEC Filings: 10-K · 10-Q